Kevin Warsh Faces Divided Fed as Inflation Pressures Complicate Rate Cut Debate JP Morgan Lowers Price Target on Banco Bilbao Vizcaya Argentaria BBVA but Retains Overweight Rating Technical Analysis Points to Bullish IntermediateTerm Outlook for Markets PutinXi Talks Rekindle Power of Siberia 2 as Iran Conflict Shakes Energy Markets Inflation Pressures Broaden Beyond Iran and Oil Shelter and Services Show Renewed Price Increases AMD Invests 128 Billion in Taiwan Chip Ecosystem Strengthening AI and Semiconductor Supply Chain OTEX Q1 2026 Earnings EPS Beats Estimates by 746 Shares Dip TC Q3 2021 Earnings Significant EPS Miss as Losses Widen Skyward Specialty Insurance Group Inc Q1 2026 Earnings EPS Beat Drives Modest Stock Gain RAVE Q3 2024 Earnings Positive EPS Amid Limited Visibility Stock Declines FGBIP Q1 2026 Earnings Earnings Beat Expectations with 96 Surprise Zepp Health ZEPP Slips 114 as Stock Tests Key Support Near 826 XFLT XAI Octagon Floating Rate Alternative Income Trust Edges Lower Amid Steady RangeBound Trading BlackRock MultiSector Income Trust BIT Edges Higher as IncomeSeeking Investors Rotate into FixedIncome CEFs J W Mays Inc MAYS Holds Steady at 414 as RangeBound Trading Persists Marchex Inc MCHX Holds Steady at 168 as Key Levels Come into Focus French Competition Regulation BelowThreshold Mergers After Doctolib Decision and Filing Threshold Increases NWSA Q1 2026 Earnings EPS Surprises to the Upside Despite Stock Decline Bright Minds Biosciences DRUG Edges Higher Amid Consolidation Near Key Support Level Copa Holdings CPA Holds Steady Near Support Amid Minimal Volatility CoStar Group Edges Lower as Market Digests Real Estate Headwinds New Mountain Finance Corporation Notes NMFCZ Holds Steady at 2530 Stability in a Volatile Market Roadzen Inc RDZN Holds Steady at 19 After Flat Session Testing Key Support Levels Rentokil Initial RTO Edges Higher as It Tests Key Resistance Levels CF Financial Corporation CFFI Faces Modest Pullback Support and Resistance Levels in Focus Assembly Biosciences ASMB Slides Over 4 as Biotech Sector Faces Pressure